FDA Alert: Dietary supplement sold on Amazon recalled for containing prescription drug ingredients

August 22, 2024

This is a reprint of an FDA Alert. Boulla LLC Issues Voluntary Nationwide Recall of Boom Max Capsules Due to the Potential Presence of Undeclared Sildenafil When a company announces a recall, market withdrawal, or safety alert, the FDA posts the company’s announcement as a public service. FDA does not endorse either the product or…

Read More
Close up of Counterfeit Accu-Chek SmartView packaging with identical serial numbers

When is Amazon liable for selling, warehousing, and delivering counterfeit medical devices?

August 21, 2024

A whistleblower complaint alleges that counterfeit and misbranded diabetes medical devices were being sold by third-party vendor on Amazon and orders were fulfilled by Amazon.com itself.

Read More

August 19, 2024: Gilead Sciences files a second suit over the sale of black market HIV drugs

August 20, 2024

A new lawsuit says that another ring has been selling counterfeit HIV medicine in the U.S. Eli Lilly is taking action against compounders selling tirzepatide. More domestic and international news.

Read More
a facebook post width images of a bottle of pills

August 12, 2024: International incidents show the breadth of the counterfeit medicine trade

August 12, 2024

A New York couple admitted to selling sildenafil in supplements they claimed were “all-natural.” Ethiopian researchers say that one-fifth of medicines in African are fake or substandard. Additional news in Canada, the U.K, Thailand and Kurdistan.

Read More

August 5, 2024: Fight the Fakes’ paper looks at how to combat substandard and counterfeit medicine

August 5, 2024

A white paper examines how to detect and respond to substandard and fake medicine. A small study shows why buying semaglutide on line is dangerous. Police in Ukraine busted a counterfeit medicine drug ring. These stories and more in this week’s news.

Read More

New studies highlight dangers of counterfeit and poorly compounded diabetes and weight-loss medicines

August 2, 2024

A study published Friday in the Journal of the American Medical Association (JAMA) underscores the urgency.

Read More

July 29, 2024: FDA issued new alert about compounded semaglutide

July 29, 2024

The FDA warns that patients are harming themselves using compounded semaglutide. Cases involving pill presses in two U.S. states and two other countries.

Read More
U-100 insuin syringe with fill volume of 5 units and 50 units

FDA alerts health care providers, compounders and patients of dosing errors associated with compounded injectable semaglutide products

July 29, 2024

FDA has received reports of adverse events, some requiring hospitalization, that may be related to overdoses due to dosing errors associated with compounded semaglutide injectable products.

Read More
Closeup of a medicine label with counterfeit features marked

July 22, 2024: A Michigan pharmacy sues supplier over fake Ozempic

July 22, 2024

A Michigan company is suing a telepharmacy that allegedly supplied fake Ozempic. New resources about the risks of compounded medicines. Details about the fake cancer drug ring busted in India.

Read More

July 15, 2024: What some fake Botox victims have endured

July 15, 2024

New information on the patients recently hurt by counterfeit Botox, two news stories involving pill presses, and a prosecution announced in Austria over fake Ozempic that sent multiple people to the hospital.

Read More